Transforming Atopic Dermatitis Management: Probiotics as a Game-Changer in Immune Modulation—A Double-Blind, Placebo-Controlled Clinical Trial
Bibliographic record
Abstract
Abstract: Background: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder characterized by immune dysregulation and microbiota imbalances. It affects millions worldwide, leading to significant morbidity and reduced quality of life. The disease is marked by intense pruritus, xerosis, and eczematous lesions, often accompanied by psychological distress and sleep disturbances. Recent research has established a strong association between gut dysbiosis and AD pathogenesis, suggesting that interventions targeting the gut microbiota may offer therapeutic benefits. Objective: This study aimed to evaluate the effects of a high-dose multistrain probiotic formulation, DSF Formulation®, on disease severity and immune modulation in adult patients with moderate-to-severe AD. Methods: A double-blind, randomized, placebo-controlled trial was conducted, enrolling 80 adult patients diagnosed with AD. Participants were randomly assigned to receive either DSF Formulation® or a placebo for 60 days. Clinical outcomes were assessed using Scoring Atopic Dermatitis (SCORAD), Eczema Area and Severity Index (EASI), and Dermatology Life Quality Index (DLQI) scoring systems, while immunological parameters were evaluated by measuring cytokine levels (IL-4, IL-10, and TGF-β) via enzyme-linked immunosorbent assay. Results: Probiotic supplementation resulted in a significant reduction in SCORAD, EASI, and DLQI scores compared to the placebo group ( P < 0.05). Additionally, a substantial decrease in IL-4 levels was observed in the probiotic-treated group, alongside a significant increase in IL-10 and TGF-β levels ( P < 0.05), indicating a shift towards an anti-inflammatory immune response. Conclusion: These findings suggest that DSF Formulation® may serve as an effective adjunctive therapy for AD by modulating the gut microbiota and promoting an anti-inflammatory immune response. Furthermore, studies are warranted to confirm these results, assess long-term clinical implications, and determine the optimal probiotic formulations for therapeutic use.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.002 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.005 | 0.002 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.003 | 0.003 |
| Insufficient payload (model declined to judge) | 0.008 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".